Status | Study |
Recruiting |
Study Name: Treatment of Soft Tissue Expansion in Inactive Thyroid Eye Disease Patients Using Drops of Prostaglandin Analogues Condition: Thyroid Associated Ophthalmopathies Date: 2014-05-21 Interventions: Drug: bimatoprost 0.03% The patients will receive a single daily drop of bimatoprost for six months. |
Completed |
Study Name: Prostaglandin F2-alpha Eye Drops in Thyroid Eye Disease (Bima Study) Condition: Graves' Ophthalmopathy Date: 2014-02-07 Interventions: Drug: Bimatoprost Other Name: |
Terminated |
Study Name: Bromocriptine and Pentoxifylline in Ophthalmopathy Autoimmune Treatment Condition: Graves Ophthalmopathy Date: 2013-06-28 Interventions: Drug: Methimazole Drug: Bromocriptine |
Active, not recruiting |
Study Name: Teprotumumab Treatment in Patients With Active Thyroid Eye Disease Condition: Thyroid Associated Ophthalmopathies Thyro Date: 2013-05-02 Interventions: Drug: teprotumumab 10mg/kg fir |
Completed |
Study Name: Twenty-four Hour Intraocular Pressure Patterns in Patients With Uncontrolled Thyroid Eye Disease Condition: Thyroid Eye Disease Date: 2013-02-21 Interventions: Device: SENSIMED Triggerfish Other Name: Contact lens sensor intented to continuously record IOP pattern |
Recruiting |
Study Name: Hyaluronic Acid Gels for Upper Lid Retraction in Active Stage Thyroid Eye Disease Condition: Thyroid Eye Disease Date: 2012-10-06 Interventions: Drug: Hyaluronic Acid Gel injection |
Completed |
Study Name: Tocilizumab Treatment in Graves´ Ophthalmopathy (Graves´ Orbitopathy or Thyroid Eye Disease) Condition: Thyroid Associated Ophthalmopathies Grave Date: 2011-02-16 Interventions: Drug: Tocilizumab (RoActemra®) |
Terminated |
Study Name: A Safety and Tolerability Study of Otelixizumab in Thyroid Eye Disease Condition: Graves Ophthalmopathy Date: 2010-04-29 Interventions: Drug: Otelixizumab - low dose |
Recruiting |
Study Name: The Effect of Early Total Thyroidectomy in the Course of Graves' Orbitopathy Condition: Graves' Ophthalmopathy Date: 2010-01-25 Interventions: Procedure: Total Thyroidectomy |
Completed |
Study Name: Trial of Rituximab for Graves' Ophthalmopathy Condition: Thyroid-associated Ophthalmopathy Date: 2008-01-01 Interventions: Drug: Rituximab Subjects will |